FDA Approval for Roche Cancer Drug Brings a New Biologic Option to Lupus Nephritis
Roche’s Gazyva, which first reached the market as a blood cancer drug, has expanded its…
FDA Approval for Roche Cancer Drug Brings a New Biologic Option to Lupus Nephritis
Roche’s Gazyva, which first reached the market as a blood cancer drug, has expanded its FDA approval to include treatment of the autoimmune disorder lupus nephritis. The CD20-targeting antibody can now compete against a blockbuster GSK drug that is the standard biologic therapy for the debilitating kidney condition. The post FDA Approval for Roche Cancer…
Concierge Care for all: What would it look like?
By MATTHEW HOLT A few weeks back I wrote an article on what’s wrong with primary care and how we should fix it. The tl:dr version was to give every American a concierge primary care physician paid for by the government. We would give everyone a $2k voucher (on average, dependent on age, medical status,…
LLMs Have Eaten the Internet — Now They’re Starving on Themselves
The way forward isn’t bigger models. It’s smaller, smarter ones. Small Language Models (SLMs) are designed to do what LLMs can’t: learn from enterprise data and focus on specific problems. The post LLMs Have Eaten the Internet — Now They’re Starving on Themselves appeared first on MedCity News.
It’s Time to Rethink Prior Authorization for Chronic and Serious Conditions
Guideline directed care pathways are a way to shift from transactional PA, where each service requires separate approval, to an episode-of-care model. The post It’s Time to Rethink Prior Authorization for Chronic and Serious Conditions appeared first on MedCity News.
Private Medicare, Medicaid Plans Exaggerate In-Network Mental Health Options, Watchdogs Say
Companies running private Medicare and Medicaid insurance plans inaccurately list many mental health professionals as being available to treat the plans’ members, a new federal watchdog report says. The investigators allege that some insurers effectively set up “ghost networks” of psychologists, psychiatrists, and other mental health professionals who purportedly have agreed to treat patients covered…
Ex-Cano Health CEO on Trial Amid $72M Fraud Claims
Marlow Hernandez, the founder and former CEO of Cano Health, is facing a jury trial this week over allegations that he fraudulently enriched himself and his family while managing the senior-focused primary care company. Cano filed for bankruptcy last year — an event many industry experts attributed to Hernandez’ poor governance. The post Ex-Cano Health…
Withings Health Solutions Expands Obesity Care Network, Launches Best Practices for Treatment Programs
Withings Health Solutions added Ilant Health to its Obesity Care Network and shared best practices to improve patient monitoring, engagement and outcomes. The post Withings Health Solutions Expands Obesity Care Network, Launches Best Practices for Treatment Programs appeared first on MedCity News.
BioCryst’s $700M Astria Acquisition Gives It a Shot to Beat Larger Rivals in Rare Disease HAE
BioCryst Pharmaceuticals’ Astria Therapeutics acquisition brings navenibart, a drug in Phase 3 testing for the rare disease hereditary angioedema. The injectable antibody has the potential to match the efficacy of the blockbuster Takeda Pharmaceutical drug that currently dominates the market, but with less burdensome dosing that could encourage HAE patients to switch. The post BioCryst’s…
Stress Test: OBBBA, Rural Fragility, and Innovation
Clinging to our old models is equivalent to waiting for failure. We need to embrace the tools, team structures, and delivery models that this ongoing crisis demands. The post Stress Test: OBBBA, Rural Fragility, and Innovation appeared first on MedCity News.
IVF Coverage Proposals Could Squeeze U.S. Fertility Clinics Without Improving Access
Ideas floated by the Trump Administration and Democrats in Congress aim to expand access to fertility treatment as an essential health benefit. But an influx of patients could collide with an already-brittle system of 430,000 annual cycles, 5,000 embryologists, and long-overdue lab upgrades. The post IVF Coverage Proposals Could Squeeze U.S. Fertility Clinics Without Improving…
